iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) was the target of some unusual options trading activity on Tuesday. Traders bought 6,917 call options on the stock. This is an increase of 113% compared to the average daily volume of 3,242 call options.

iShares Nasdaq Biotechnology Index Fund (IBB) opened at 340.48 on Friday. The firm’s 50-day moving average is $328.37 and its 200-day moving average is $308.12. iShares Nasdaq Biotechnology Index Fund has a 1-year low of $246.71 and a 1-year high of $342.50.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 29th. Stockholders of record on Wednesday, September 27th were paid a $0.119 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend was Tuesday, September 26th.

Hedge funds have recently made changes to their positions in the company. Sei Investments Co. raised its stake in shares of iShares Nasdaq Biotechnology Index Fund by 297.0% in the 1st quarter. Sei Investments Co. now owns 401 shares of the financial services provider’s stock valued at $118,000 after buying an additional 300 shares in the last quarter. Bollard Group LLC raised its stake in shares of iShares Nasdaq Biotechnology Index Fund by 0.3% in the 2nd quarter. Bollard Group LLC now owns 392 shares of the financial services provider’s stock valued at $121,000 after buying an additional 1 shares in the last quarter. WMS Partners LLC acquired a new position in shares of iShares Nasdaq Biotechnology Index Fund in the 1st quarter valued at $200,000. Fairview Capital Investment Management LLC acquired a new position in shares of iShares Nasdaq Biotechnology Index Fund in the 1st quarter valued at $203,000. Finally, Bfsg LLC bought a new stake in shares of iShares Nasdaq Biotechnology Index Fund in the 1st quarter worth about $226,000. Institutional investors own 57.87% of the company’s stock.

TRADEMARK VIOLATION WARNING: “iShares Nasdaq Biotechnology Index Fund Target of Unusually High Options Trading (IBB)” was originally posted by Watch List News and is owned by of Watch List News. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.watchlistnews.com/ishares-nasdaq-biotechnology-index-fund-target-of-unusually-high-options-trading-ibb/1616424.html.

iShares Nasdaq Biotechnology Index Fund Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Receive News & Ratings for iShares Nasdaq Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology Index Fund and related companies with Analyst Ratings Network's FREE daily email newsletter.